Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7433792 | 0.87 | HTR4 (0.48) | HTR4 | |
| Hydrochloric Acid SCHEMBL8870522 | 0.86 | HTR4 (0.47) | HTR4 | |
| SCHEMBL7436666 | 0.83 | HTR4 (0.44) | HTR4DRD2 | |
| SCHEMBL5318148 | 0.71 | KDM4E (0.53) | HTR4 | |
| SCHEMBL7434391 | 0.71 | DRD2 (0.40) | DRD2 | |
| Hydrochloric Acid SCHEMBL8871742 | 0.70 | DRD2 (0.40) | DRD2 | |
| SCHEMBL5318149 | 0.70 | HTR4 (0.41) | HTR4 | |
| SCHEMBL8048001 | 0.69 | HTR4 (0.64) | HTR4 | |
| SCHEMBL5316403 | 0.68 | SMN1; SMN2 (0.44) | HTR4 | |
| SCHEMBL17978312 | 0.66 | HTR4 (0.46) | HTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5663173-A | CENTRAL NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS, PYCHOSES, ANTIDEPRESSANTS AND EATING DISORDERS | SYNTHELABO (FR) | 1997-09-02 | — | — | US | claimed |
| EP-0748807-A1 | Derivatives of N-(1,4-diazabicyclo(2.2.2)-oct-2-yl)methyl benzamide, their preparation and their therapeutical use | SYNTHELABO (FR) | 1996-12-18 | — | — | EP | claimed |
| US-5663173-A | CENTRAL NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS, PYCHOSES, ANTIDEPRESSANTS AND EATING DISORDERS | SYNTHELABO (FR) | 1997-09-02 | — | — | US | disclosed |
| EP-0748807-A1 | Derivatives of N-(1,4-diazabicyclo(2.2.2)-oct-2-yl)methyl benzamide, their preparation and their therapeutical use | SYNTHELABO (FR) | 1996-12-18 | — | — | EP | disclosed |